How a Japanese Drugmaker Got The ‘Clean Win’ Over Alzheimer’s
Eisai a Tokyo-based pharmaceutical company with a family bent and market capitalization of $14 billion, crossed the finish line before behemoths valued nearly 20-fold higher, including industry leaders Roche Holding AG and Eli Lilly & The results of…
Read More